Abstract
Treatments for HIV have advanced rapidly over the past decade. Andrew Phillips and colleagues argue that we should re-evaluate the timing of treatment in the light of new knowledge
MeSH terms
-
Acquired Immunodeficiency Syndrome / prevention & control
-
Antiretroviral Therapy, Highly Active*
-
CD4 Lymphocyte Count
-
HIV Infections / drug therapy*
-
Humans
-
Risk Factors